170 related articles for article (PubMed ID: 15265190)
81. Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese.
Li X; Zhang J; Wu X; Yan H; Zhang Y; He RH; Tang YJ; He YJ; Tan D; Mao XY; Yin JY; Liu ZQ; Zhou HH; Liu J
Pharmacogenomics; 2016 Dec; 17(18):2007-2014. PubMed ID: 27918244
[TBL] [Abstract][Full Text] [Related]
82. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K
Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882
[TBL] [Abstract][Full Text] [Related]
83. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.
de Schepper J; Hachimi-Idrissi S; Louis O; Maurus R; Otten J
Arch Dis Child; 1994 Oct; 71(4):346-8. PubMed ID: 7979531
[TBL] [Abstract][Full Text] [Related]
84. Fragility fractures and reversible osteopaenia due to chronic hyponatraemia in an adolescent male.
Patel M; Ayus JC; Moritz ML
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31352389
[TBL] [Abstract][Full Text] [Related]
85. Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine.
Rieger-Wettengl G; Tutlewski B; Stabrey A; Rauch F; Herkenrath P; Schauseil-Zipf U; Schoenau E
Pediatrics; 2001 Dec; 108(6):E107. PubMed ID: 11731634
[TBL] [Abstract][Full Text] [Related]
86. Bone mineral density in children with beta-thalassemia major in Diyarbakir.
Pirinççioğlu AG; Akpolat V; Köksal O; Haspolat K; Söker M
Bone; 2011 Oct; 49(4):819-23. PubMed ID: 21798385
[TBL] [Abstract][Full Text] [Related]
87. Does long-term use of valproate cause weight gain in prepubertal epileptic children?
Caksen H; Deda G; Berberoğlu M
Int J Neurosci; 2002 Oct; 112(10):1183-9. PubMed ID: 12587521
[TBL] [Abstract][Full Text] [Related]
88. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children.
Chung S; Ahn C
Brain Dev; 1994; 16(5):382-5. PubMed ID: 7892957
[TBL] [Abstract][Full Text] [Related]
89. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats.
Onodera K; Takahashi A; Sakurada S; Okano Y
Life Sci; 2002 Feb; 70(13):1533-42. PubMed ID: 11895104
[TBL] [Abstract][Full Text] [Related]
90. Risk of valproic acid-related alopecia: A systematic review and meta-analysis.
Wang X; Wang H; Xu D; Zhu L; Liu L
Seizure; 2019 Jul; 69():61-69. PubMed ID: 30981051
[TBL] [Abstract][Full Text] [Related]
91. Flaxseed (linum usitatissimum) flour contributes to bone health in adult male rats.
Maíra DCA; Letícia RP; Rodrigues da Costa L; Ferolla da Camara Boueri B; Carolina RP; D'Avila Pereira A; Cavalcante Ribeiro D; Moreira da Silva E; Soares da Costa CA; Gilson TB
Nutrition; 2018 May; 49():48-50. PubMed ID: 29494999
[TBL] [Abstract][Full Text] [Related]
92. Renal tubular dysfunction in epileptic children on valproic acid therapy.
Altunbaşak S; Yildizaş D; Anarat A; Burgut HR
Pediatr Nephrol; 2001 Mar; 16(3):256-9. PubMed ID: 11322374
[TBL] [Abstract][Full Text] [Related]
93. The effects of valproate on serum leptin, insulin, and lipid levels in epileptic children.
Kilic H; Demirel A; Uysal S
Pediatr Int; 2021 Nov; 63(11):1351-1356. PubMed ID: 33657654
[TBL] [Abstract][Full Text] [Related]
94. The platelet aggregation in children with epilepsy receiving valproic acid.
Tanindi S; Akin R; Koseoglu V; Kurekci AE; Gokcay E; Ozcan O
Thromb Res; 1996 Feb; 81(4):471-6. PubMed ID: 8907296
[TBL] [Abstract][Full Text] [Related]
95. Effect of duration of sodium valproate therapy on bone mineral density and vitamin D levels.
Nirmal D; Abdul S; Jaiswal P; Naunihal Singh S; Avaragollapuravarga Mathada A; Nagaraj P
Epilepsy Behav; 2024 Apr; 153():109733. PubMed ID: 38447300
[TBL] [Abstract][Full Text] [Related]
96. Endocrine and metabolic changes in epileptic patients receiving valproic acid.
Verrotti A; Greco R; Latini G; Chiarelli F
J Pediatr Endocrinol Metab; 2005 May; 18(5):423-30. PubMed ID: 15921170
[TBL] [Abstract][Full Text] [Related]
97. Effect of valproate on bone mineral density.
Gilles P; Alliët P; Bruneel E; Raes M
J Pediatr; 1996 Mar; 128(3):441. PubMed ID: 8774525
[No Abstract] [Full Text] [Related]
98. [State of bone in children living in different conditions of environment].
Luchynskyi MA; Luchynskyi VM; Palasyuk BO; Luchynska II; Patskan LO; Stakhanska OО
Wiad Lek; 2018; 71(9):1722-1728. PubMed ID: 30737930
[TBL] [Abstract][Full Text] [Related]
99. Bone mineral density in pediatric patients with idiopathic hypercalciuria.
García-Nieto V; Ferrández C; Monge M; de Sequera M; Rodrigo MD
Pediatr Nephrol; 1997 Oct; 11(5):578-83. PubMed ID: 9323283
[TBL] [Abstract][Full Text] [Related]
100. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study.
Kubota F; Kifune A; Shibata N; Akata T; Takeuchi K; Takahashi S; Ohsawa M; Takama F
Epilepsy Res; 1999 Feb; 33(2-3):93-7. PubMed ID: 10094421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
